BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8565230)

  • 21. Plasma levels of 7-hydroxymethotrexate after high-dose methotrexate treatment.
    Milano G; Thyss A; Renee N; Schneider M; Namer M; Boublil JL; Lalanne CM
    Cancer Chemother Pharmacol; 1983; 11(1):29-32. PubMed ID: 6883624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between oral mucositis and high-dose methotrexate therapy in pediatric acute lymphoblastic leukemia.
    Maiguma T; Hayashi Y; Ueshima S; Kaji H; Egawa T; Chayama K; Morishima T; Kitamura Y; Sendo T; Gomita Y; Teshima D
    Int J Clin Pharmacol Ther; 2008 Nov; 46(11):584-90. PubMed ID: 19000557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [l-folinic acid versus racemic folinic acid in the treatment of leukemia in children with high dose of methotrexate].
    Etienne MC; Thyss A; Bertrand Y; Rubie H; Milano G
    Bull Cancer; 1993 Apr; 80(4):357-63. PubMed ID: 8173189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma 7-Hydroxymethotrexate Levels Versus Methotrexate to Predict Delayed Elimination in Children Receiving High-Dose Methotrexate.
    Fabresse N; Devictor B; Pissier C; Chambost H; Lacarelle B; Michel G; Solas C
    Ther Drug Monit; 2018 Feb; 40(1):76-83. PubMed ID: 29120974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous determination of methotrexate and its eight metabolites in human whole blood by capillary zone electrophoresis.
    Kuo CY; Wu HL; Kou HS; Chiou SS; Wu DC; Wu SM
    J Chromatogr A; 2003 Oct; 1014(1-2):93-101. PubMed ID: 14558615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Investigation on individualized adjustment of target range of high-dose methotrexate].
    Hua Y; Zhao WH; Lu XT; Yang LH; Lu W
    Zhonghua Er Ke Za Zhi; 2008 Mar; 46(3):203-8. PubMed ID: 19099710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved sensitivity for methotrexate analysis using enzyme multiplied immunoassay technique on the Siemens Viva-E instrument.
    Borgman MP; Hiemer MF; Molinelli AR; Ritchie JC; Jortani SA
    Ther Drug Monit; 2012 Apr; 34(2):193-7. PubMed ID: 22377747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrafast selective quantification of methotrexate in human plasma by high-throughput MALDI-isotope dilution mass spectrometry.
    Meesters RJ; den Boer E; Mathot RA; de Jonge R; van Klaveren RJ; Lindemans J; Luider TM
    Bioanalysis; 2011 Jun; 3(12):1369-78. PubMed ID: 21679031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate after high-dose (33.6 g/m2) methotrexate therapy.
    Slørdal L; Kolmannskog S; Prytz PS; Moe PJ; Aarbakke J
    Pediatr Hematol Oncol; 1986; 3(2):127-34. PubMed ID: 3153222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of enzyme immunoassay, radioassay, and radioimmunoassay of serum methotrexate, as compared with liquid chromatography.
    Buice RG; Evans WE; Karas J; Nicholas CA; Sidhu P; Straughn AB; Meyer MC; Crom WR
    Clin Chem; 1980 Dec; 26(13):1902-4. PubMed ID: 7002366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma homocysteine in children with acute lymphoblastic leukemia: changes during a chemotherapeutic regimen including methotrexate.
    Refsum H; Wesenberg F; Ueland PM
    Cancer Res; 1991 Feb; 51(3):828-35. PubMed ID: 1988122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and validation of LC-MS/MS assay for the simultaneous determination of methotrexate, 6-mercaptopurine and its active metabolite 6-thioguanine in plasma of children with acute lymphoblastic leukemia: Correlation with genetic polymorphism.
    Al-Ghobashy MA; Hassan SA; Abdelaziz DH; Elhosseiny NM; Sabry NA; Attia AS; El-Sayed MH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Dec; 1038():88-94. PubMed ID: 27802917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy, side effects and blood concentration monitoring of high-dose methotrexate in treatment of 180 children with acute lymphoblastic leukemia].
    Wang H; Chi ZF; Li S; Wang XL; Hao LC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):949-52. PubMed ID: 21867621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous quantitation of methotrexate and its two main metabolites in biological fluids by a novel solid-phase extraction procedure using high-performance liquid chromatography.
    Albertioni F; Pettersson B; Beck O; Rask C; Seideman P; Peterson C
    J Chromatogr B Biomed Appl; 1995 Mar; 665(1):163-70. PubMed ID: 7795788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trace analysis of methotrexate and 7-hydroxymethotrexate in human plasma and urine by a novel high-performance liquid chromatographic method.
    Beck O; Seideman P; Wennberg M; Peterson C
    Ther Drug Monit; 1991 Nov; 13(6):528-32. PubMed ID: 1771651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of cyclosporine measurement in whole blood by high-performance liquid chromatography, monoclonal fluorescence polarization immunoassay, and monoclonal enzyme-multiplied immunoassay.
    Dusci LJ; Hackett LP; Chiswell GM; Ilett KF
    Ther Drug Monit; 1992 Aug; 14(4):327-32. PubMed ID: 1519308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of four immunoassays to an HPLC method for the therapeutic drug monitoring of methotrexate: Influence of the hydroxylated metabolite levels and impact on clinical threshold.
    Descoeur J; Dupuy AM; Bargnoux AS; Cristol JP; Mathieu O
    J Oncol Pharm Pract; 2022 Jan; 28(1):55-63. PubMed ID: 33427019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of renal function during high-dose methotrexate treatment in children with acute lymphoblastic leukemia.
    Ylinen E; Jahnukainen K; Saarinen-Pihkala UM; Jahnukainen T
    Pediatr Blood Cancer; 2014 Dec; 61(12):2199-202. PubMed ID: 25174822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CSF drug levels for children with acute lymphoblastic leukemia treated by 5 g/m2 methotrexate. A study from the EORTC Children's Leukemia Cooperative Group.
    Milano G; Thyss A; Serre Debeauvais F; Laureys G; Benoit Y; Deville A; Dutour C; Robert A; Otten J; Behar C
    Eur J Cancer; 1990 Apr; 26(4):492-5. PubMed ID: 2141516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient characteristics associated with high-risk methotrexate concentrations and toxicity.
    Relling MV; Fairclough D; Ayers D; Crom WR; Rodman JH; Pui CH; Evans WE
    J Clin Oncol; 1994 Aug; 12(8):1667-72. PubMed ID: 8040679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.